Latest News
Accord BioPharma's second pegfilgrastim biosimilar to NEULASTA approved by US FDA
10 July 2026 - Accord BioPharma, the US specialty division of India-based Intas Pharmaceuticals Ltd, focused on the development of oncology, immunology, and central nervous system (CNS) therapies, announced on Thursday that the US Food and Drug Admin...
Biohaven announces scientific leadership changes
10 July 2026 - Biopharmaceutical company Biohaven Ltd (NYSE:BHVN) announced on Wednesday scientific leadership role transitions designed to accelerate drug innovation and external collaborations.David Pirman, Ph.D., has been promoted to executive vic...
Labcorp declares quarterly dividend of USD0.72 per share
10 July 2026 - Laboratory services provider Labcorp Holdings Inc (NYSE:LH) announced on Thursday that its board of directors has declared a cash dividend of USD0.72 per share of common stock.This amount is unchanged from the previous quarterly divide...
DIA and MHRA plan global regulatory science summit in London
10 July 2026 - The Drug Information Association (DIA), a US-based advisory organisation, and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) announced on Thursday the DIA-MHRA Global Summit: Global Collaboration for Safer and...
MetaVia completes DA-1726 dose titration in Phase 1 Part 3 study for obesity treatment
10 July 2026 - Clinical-stage biotechnology company MetaVia Inc (Nasdaq:MTVA) announced on Thursday that all enrolled active patients in Part 3 of its Phase 1 clinical trial evaluating DA-1726 for the treatment of obesity have successfully completed ...